why choose us

First received: April 27, 2023

Clinical Trial: TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Lymphoblastic Leukemia

Study Type: INTERVENTIONAL


Official Title: TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Brief Summary: The purpose of this study is to improve upon the TINI study treatment.The study will test the ability of a type of immunotherapy called blinatumomab to clear persistent leukemia.Blinatumomab targets CD19 which is located on the leukemia cells outer membrane.

Read more